Ignite Creation Date:
2024-05-06 @ 3:45 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04746287
Status:
COMPLETED
Last Update Posted:
2022-05-04
First Post:
2021-01-15
Brief Title:
Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects
Sponsor:
Chong Kun Dang Pharmaceutical
Organization:
Chong Kun Dang Pharmaceutical
Study Overview
Official Title:
First-in-Human Randomized Double-blind Placebo-controlled Study to Evaluate Safety Tolerability Pharmacokinetics Pharmacodynamics and Food Effects of CKD-510 in Single Ascending Dose and Multiple Ascending Dose in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2022-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a first-in-human study of CKD-510 in single-ascending dose and multiple-ascending dose in healthy subjects This trial is a randomized double-blind placebo-controlled study to evaluate the safety tolerability pharmacokinetics pharmacodynamics of food effects of CKD-510
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None